Search images on Google      Product Monograph

Active Ingredients:

• casirivimab, 1332 MG/11.1 ML
• imdevimab, 1332 MG/11.1 ML

DIN: 02516705

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE-USE VIALS

Schedule: COVID-19 - IO - Authorization

Company: HOFFMANN-LA ROCHE LIMITED  –  official site

ATC:

• J06 - IMMUNE SERA AND IMMUNOGLOBULINS (ATC, WHO, Wiki)
• J06B - IMMUNOGLOBULINS (ATC, WHO)
• J06BD - (ATC, WHO)
• J06BD07 - CASIRIVIMAB AND IMDEVIMAB (WHO)

 

External Links for Casirivimab And Imdevimab:

Search on Google

• Casirivimab And Imdevimab side effects
• Casirivimab And Imdevimab dosage
• casirivimab side effects
• casirivimab dosage
• imdevimab side effects
• imdevimab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find casirivimab and imdevimab photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.